Calyxt Inc (CLXT) CEO James Blome Sells 2,582 Shares
Calyxt Inc (NASDAQ:CLXT) CEO James Blome sold 2,582 shares of the company’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $16.58, for a total transaction of $42,809.56. Following the completion of the sale, the chief executive officer now directly owns 161,882 shares of the company’s stock, valued at approximately $2,684,003.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
CLXT stock traded up $0.54 during trading on Friday, hitting $17.01. The company had a trading volume of 133,317 shares, compared to its average volume of 60,071. The company has a market capitalization of $537.11 million, a P/E ratio of -18.69 and a beta of 2.78. Calyxt Inc has a fifty-two week low of $8.83 and a fifty-two week high of $22.32. The company has a quick ratio of 15.01, a current ratio of 15.01 and a debt-to-equity ratio of 0.17.
Calyxt (NASDAQ:CLXT) last issued its quarterly earnings results on Monday, March 11th. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.01). Calyxt had a negative return on equity of 32.15% and a negative net margin of 11,820.76%. Equities analysts anticipate that Calyxt Inc will post -1.05 EPS for the current year.
Several equities research analysts recently weighed in on the stock. National Securities reaffirmed a “buy” rating and issued a $35.00 price objective on shares of Calyxt in a report on Wednesday. Zacks Investment Research raised shares of Calyxt from a “sell” rating to a “hold” rating in a report on Tuesday, March 12th. Finally, Citigroup upped their price objective on shares of Calyxt from $13.00 to $16.00 and gave the stock a “neutral” rating in a report on Wednesday, February 27th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Calyxt currently has an average rating of “Buy” and a consensus price target of $21.80.
Calyxt Company Profile
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.
See Also: What is a front-end load?
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.